{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:44:26Z","timestamp":1790891066954,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.bcp.2008.05.032","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T04:16:54Z","timestamp":1213762614000},"page":"482-494","source":"Crossref","is-referenced-by-count":65,"title":["The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB\/Akt and NF-\u03baB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats"],"prefix":"10.1016","volume":"76","author":[{"given":"A.","family":"Ochaion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bar-Yehuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.V.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.G.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Patoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Del Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Perez-Liz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2008.05.032_bib1","first-page":"469","article-title":"The anti-inflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models","volume":"32","author":"Baharav","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.bcp.2008.05.032_bib2","first-page":"1","article-title":"The PI3K\u2013NF-\u03baB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis","volume":"8","author":"Fishman","year":"2006","journal-title":"Art Res Ther"},{"key":"10.1016\/j.bcp.2008.05.032_bib3","first-page":"400","article-title":"IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis","volume":"24","author":"Rath-Wolfson","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.bcp.2008.05.032_bib4","first-page":"20","article-title":"Over-expression of A3 adenosine receptor in PBMC of rheumatoid arthritis patients: involvement of NF-\u03baB in mediating receptor level","volume":"34","author":"Madi","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bcp.2008.05.032_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5414\/CPP42534","article-title":"Tolerability, pharmacokinetics, and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men","volume":"42","author":"van Troostenburg","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2008.05.032_bib6","first-page":"1","article-title":"Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial","volume":"35","author":"Silverman","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bcp.2008.05.032_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.2001.tb03615.x","article-title":"Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke","volume":"939","author":"von Lubitz","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bcp.2008.05.032_bib8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0301-472X(02)00962-1","article-title":"Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents","volume":"30","author":"Bar-Yehuda","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bcp.2008.05.032_bib9","doi-asserted-by":"crossref","first-page":"H2780","DOI":"10.1152\/ajpheart.00411.2003","article-title":"Novel N6-substituted adenosine 5\u2032-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury","volume":"285","author":"Tracey","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.bcp.2008.05.032_bib10","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/j.1600-6143.2004.00620.x","article-title":"Activation of A3 adenosine receptor provides lung protection against ischemia-reperfusion injury associated with reduction in apoptosis","volume":"4","author":"Rivo","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bcp.2008.05.032_bib11","doi-asserted-by":"crossref","first-page":"R957","DOI":"10.1152\/ajpregu.00034.2006","article-title":"A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis","volume":"291","author":"Lee","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bcp.2008.05.032_bib12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1021\/jm049580r","article-title":"(N)-Methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists","volume":"48","author":"Tchilibon","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2008.05.032_bib13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2174\/156802605774463079","article-title":"Purine derivatives as ligands for A3 adenosine receptors","volume":"5","author":"Joshi","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2008.05.032_bib14","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/cc4893","article-title":"A3 adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion","volume":"10","author":"Matot","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.bcp.2008.05.032_bib15","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2008.05.032_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0003-2697(90)90113-N","article-title":"A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid","volume":"189","author":"Nordstedt","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2008.05.032_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-2999(03)01570-X","article-title":"The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5\u2032-N-methyluronamide, is protective in two murine models of colitis","volume":"466","author":"Mabley","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2008.05.032_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00054725-200608000-00014","article-title":"ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis","volume":"12","author":"Guzman","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bcp.2008.05.032_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.11.004","article-title":"Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase\/Akt and NF-kappaB activation in murine BV2 microglial cells","volume":"396","author":"Lee","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bcp.2008.05.032_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.105.091868","article-title":"Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1\/2","volume":"316","author":"Martin","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2008.05.032_bib21","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/ar2078","article-title":"Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression","volume":"8","author":"Ochaion","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bcp.2008.05.032_bib22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1517\/13543784.16.10.1601","article-title":"The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis","volume":"16","author":"Bar-Yehuda","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bcp.2008.05.032_bib23","series-title":"Adenosine receptors: therapeutic aspects for inflammatory and immune diseases","first-page":"299","author":"Fishman","year":"2007"},{"key":"10.1016\/j.bcp.2008.05.032_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0092-8674(88)90532-6","article-title":"Two distinct subpopulations of endosomes involved in membrane recycling and transport to lysosomes","volume":"52","author":"Schmid","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2008.05.032_bib25","doi-asserted-by":"crossref","first-page":"42121","DOI":"10.1074\/jbc.M301243200","article-title":"A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition","volume":"278","author":"Madi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.05.032_bib26","doi-asserted-by":"crossref","first-page":"49571","DOI":"10.1074\/jbc.C400442200","article-title":"Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity","volume":"279","author":"Buss","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.05.032_bib27","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/01.CCM.0000178350.21839.44","article-title":"GSK-3beta inhibitors attenuate the organ injury\/dysfunction caused by endotoxemia in the rat","volume":"33","author":"Dugo","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bcp.2008.05.032_bib28","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-04-3642","article-title":"Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells","volume":"65","author":"Ougolkov","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2008.05.032_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjp.0706509","article-title":"Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta","volume":"147","author":"Whittle","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2008.05.032_bib30","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.febslet.2005.06.049","article-title":"Diclofenac attenuates Wnt\/beta-catenin signaling in colon cancer cells by activation of NF-kappaB","volume":"579","author":"Cho","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2008.05.032_bib31","doi-asserted-by":"crossref","first-page":"40450","DOI":"10.1074\/jbc.M507553200","article-title":"Acetylation of poly(ADP-ribose) polymerase-1 by p300\/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription","volume":"280","author":"Hassa","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2008.05.032_bib32","doi-asserted-by":"crossref","first-page":"G129","DOI":"10.1152\/ajpgi.00515.2004","article-title":"Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells","volume":"289","author":"Sun","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bcp.2008.05.032_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1165\/rcmb.2006-0059OC","article-title":"Expression of JP-8-induced inflammatory genes in AEII cells is mediated by NF-kappaB and PARP-1","volume":"35","author":"Espinoza","year":"2006","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208003791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295208003791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T08:35:31Z","timestamp":1549614931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295208003791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0006295208003791"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2008.05.032","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}